Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4

Fangfang Zha1, Xiaolu Qu2, Bo Tang1

  • 1Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu District, Shanghai 201700, P.R. China.

Aging
|June 14, 2019
PubMed

Insights

Long non-coding RNA MEG3 exacerbates diabetic nephropathy (DN) by promoting fibrosis and inflammation. It acts as a sponge for miR-181a, regulating the Egr-1/TLR4 pathway in kidney cells.

Area of Science:

  • Molecular Biology
  • Genetics
  • Nephrology

Background:

  • Diabetic nephropathy (DN) is a severe complication of diabetes.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in DN pathogenesis.
  • Understanding specific lncRNAs like MEG3 is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of long non-coding RNA MEG3 in diabetic nephropathy (DN).
  • To elucidate the molecular mechanisms underlying MEG3's function in DN.
  • To explore the interaction between MEG3, miR-181a, and the Egr-1/TLR4 signaling pathway.

Main Methods:

  • In vivo and in vitro models of diabetic nephropathy.
  • Quantitative real-time PCR to measure MEG3 and miR-181a expression.
  • Western blotting to assess protein levels (Egr-1, TLR4).
  • RNA immunoprecipitation assays to confirm Ago2-dependent interactions.

Main Results:

  • MEG3 expression was significantly upregulated in DN models.
  • MEG3 overexpression enhanced fibrosis and inflammatory responses in mesangial cells.
  • MEG3 acted as an endogenous sponge for miR-181a, inhibiting its function.
  • MiR-181a directly targeted Egr-1, and its inhibition promoted DN-related cellular changes.
  • MEG3 promoted DN progression via the miR-181a/Egr-1/TLR4 signaling axis.

Conclusions:

  • MEG3 plays a pro-fibrotic and pro-inflammatory role in diabetic nephropathy.
  • The MEG3/miR-181a/Egr-1/TLR4 axis represents a novel regulatory pathway in DN.
  • Targeting MEG3 or its downstream effectors may offer therapeutic strategies for DN.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.1K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.5K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.7K